Autism Spectrum Disorder as a Multifactorial Disorder: The Interplay of Genetic Factors and Inflammation.
Ayoub George
What this study means for families
This review looks at autism as a complex condition caused by multiple factors. The main contributors appear to be genetic differences (including those affecting how the brain processes folate) and exposure to inflammatory triggers during pregnancy and after birth. These factors work together during important developmental periods, potentially leading to the social, behavioral, and sensory challenges seen in autism.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Research summary
This review examines autism spectrum disorder (ASD) as a multifactorial condition involving genetic susceptibilities and environmental inflammatory exposures that lead to oxidative stress during critical developmental periods. The authors explore how genetic variations, including those affecting cerebral folate metabolism, interact with inflammatory triggers during both fetal and post-fetal periods to influence ASD development and specific autism symptoms. The research emphasizes the complex interplay between genetics and inflammation in ASD etiology, highlighting the need to understand these interconnected pathways for potential intervention targets.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Key findings
- 1
ASD etiology involves interplay between genetic susceptibilities and environmental inflammatory exposures
Confidence: moderateRelevance: Understanding multifactorial nature may inform comprehensive assessment and intervention approaches - 2
Genetic variations affecting cerebral folate metabolism contribute to ASD development
Confidence: moderateRelevance: May support folate supplementation strategies and genetic screening considerations - 3
Inflammatory triggers during fetal and post-fetal periods influence ASD development
Confidence: moderateRelevance: Highlights importance of reducing inflammatory exposures during pregnancy and early development
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Clinical implications
Findings suggest ASD may benefit from multi-pronged approaches addressing both genetic factors (such as folate metabolism support) and inflammatory reduction strategies during critical developmental periods. However, specific clinical applications require further validation through controlled studies.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Limitations
As a narrative review without systematic methodology details, the evidence synthesis approach is unclear. No sample size or specific study selection criteria are reported, limiting assessment of comprehensiveness and potential bias in the literature reviewed.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Original abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by difficulty with social communication, behavior, and sensory integration. With its prevalence rising worldwide in recent decades, understanding and mitigating the origins of ASD has become a priority. Though its etiology is multifactorial, the current research highlights two major contributors, genetic susceptibilities and environmental inflammatory exposures, leading to oxidative stress during critical developmental periods. We explore how genetic variations, including those affecting cerebral folate metabolism, and various inflammatory triggers, including exposure to inflammatory agents during both the fetal and post-fetal period, intersect to influence the development of ASD, giving rise to specific symptoms seen in autism.
Evidence Grade
limited
Grade assigned by AutismInsights based on study type and published abstract.
Study Details
- Type
- Review
- Journal
- International journal of molecular sciences
- Year
- 2025
- PMID
- 40650268
- DOI
- 10.3390/ijms26136483
MeSH Terms